| Primary |
| Hiv Infection |
66.4% |
| Antiretroviral Therapy |
11.6% |
| Tuberculosis |
6.9% |
| Prophylaxis Against Transplant Rejection |
2.3% |
| Hiv Test Positive |
1.7% |
| Prophylaxis |
1.7% |
| Pathogen Resistance |
1.2% |
| Hypertension |
1.0% |
| Acquired Immunodeficiency Syndrome |
0.9% |
| Antifungal Prophylaxis |
0.9% |
| Meningitis Tuberculous |
0.7% |
| Type 2 Diabetes Mellitus |
0.6% |
| Antiviral Prophylaxis |
0.6% |
| Depression |
0.6% |
| Infection |
0.6% |
| Hiv Test |
0.5% |
| Mycobacterial Infection |
0.5% |
| Adverse Event |
0.5% |
| Atypical Mycobacterial Infection |
0.5% |
| Cerebral Toxoplasmosis |
0.5% |
|
| Pregnancy |
34.2% |
| Drug Screen False Positive |
7.3% |
| Vomiting |
6.8% |
| Drug Screen Positive |
5.9% |
| Rash |
4.9% |
| Adverse Event |
4.2% |
| Pyrexia |
3.7% |
| Thrombocytopenia |
3.4% |
| Myocardial Infarction |
3.2% |
| Vertigo |
3.2% |
| Nervous System Disorder |
2.9% |
| Urine Colour Abnormal |
2.7% |
| Nightmare |
2.4% |
| Weight Decreased |
2.4% |
| Death |
2.2% |
| Medication Residue |
2.2% |
| Somnolence |
2.2% |
| Ventricular Septal Defect |
2.2% |
| Immune Reconstitution Syndrome |
2.0% |
| Insomnia |
2.0% |
|
| Secondary |
| Hiv Infection |
60.3% |
| Drug Use For Unknown Indication |
8.2% |
| Antiretroviral Therapy |
6.3% |
| Tuberculosis |
5.7% |
| Antiviral Treatment |
3.2% |
| Drug Exposure During Pregnancy |
2.9% |
| Product Used For Unknown Indication |
2.8% |
| Prophylaxis |
1.6% |
| Hiv Test Positive |
1.2% |
| Antifungal Prophylaxis |
1.2% |
| Depression |
1.1% |
| Hypertension |
0.9% |
| Antiviral Prophylaxis |
0.9% |
| Pain |
0.7% |
| Medical Diet |
0.6% |
| Acquired Immunodeficiency Syndrome |
0.5% |
| Anaemia |
0.5% |
| Maternal Exposure Timing Unspecified |
0.5% |
| Prophylaxis Against Transplant Rejection |
0.5% |
| Prophylaxis Against Hiv Infection |
0.5% |
|
| Drug Exposure During Pregnancy |
9.9% |
| Pyrexia |
9.9% |
| Abortion Spontaneous |
7.0% |
| Weight Decreased |
6.7% |
| Renal Failure |
6.3% |
| Thrombocytopenia |
6.0% |
| Vomiting |
5.6% |
| Pregnancy |
5.3% |
| Microcephaly |
4.9% |
| Neutropenia |
4.9% |
| Myocardial Infarction |
3.9% |
| Progressive External Ophthalmoplegia |
3.9% |
| Stillbirth |
3.5% |
| Varices Oesophageal |
3.5% |
| Completed Suicide |
3.2% |
| Hepatotoxicity |
3.2% |
| Rash |
3.2% |
| Renal Failure Acute |
3.2% |
| Urogenital Disorder |
3.2% |
| Ectopic Pregnancy |
2.8% |
|
| Concomitant |
| Hiv Infection |
55.8% |
| Drug Use For Unknown Indication |
10.1% |
| Drug Exposure During Pregnancy |
7.3% |
| Product Used For Unknown Indication |
4.2% |
| Pain |
2.9% |
| Depression |
2.6% |
| Tuberculosis |
2.1% |
| Hypertension |
2.0% |
| Hepatitis C |
1.9% |
| Insomnia |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Disseminated Tuberculosis |
1.4% |
| Hiv Test Positive |
1.2% |
| Prophylaxis |
1.2% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Arthritis |
0.8% |
| Nausea |
0.8% |
| Pulmonary Hypertension |
0.8% |
| Anxiety |
0.7% |
| Antiretroviral Therapy |
0.6% |
|
| Renal Failure Acute |
9.3% |
| Viral Load Increased |
8.4% |
| Rash |
8.0% |
| Vomiting |
8.0% |
| Weight Decreased |
7.5% |
| Renal Failure |
6.2% |
| Thrombocytopenia |
5.8% |
| Ventricular Septal Defect |
4.9% |
| Pregnancy |
4.4% |
| Rectal Haemorrhage |
4.4% |
| Nausea |
4.0% |
| Abortion Spontaneous |
3.5% |
| Osteonecrosis |
3.5% |
| Renal Tubular Disorder |
3.5% |
| Haemoglobin Decreased |
3.1% |
| Pancreatitis |
3.1% |
| Pancreatitis Acute |
3.1% |
| Spinal X-ray Abnormal |
3.1% |
| Squamous Cell Carcinoma |
3.1% |
| Suicidal Ideation |
3.1% |
|
| Interacting |
| Hiv Infection |
30.8% |
| Product Used For Unknown Indication |
30.8% |
| Drug Use For Unknown Indication |
26.9% |
| Acquired Immunodeficiency Syndrome |
9.6% |
| Thrombophlebitis |
1.9% |
|
| Renal Tubular Necrosis |
21.4% |
| Unevaluable Event |
21.4% |
| Pregnancy |
14.3% |
| Drug Ineffective |
7.1% |
| Neuropathy Peripheral |
7.1% |
| Pulmonary Embolism |
7.1% |
| Tearfulness |
7.1% |
| Visual Acuity Reduced |
7.1% |
| Vomiting |
7.1% |
|
